Archive | Medical innovation RSS feed for this section

Specialty pharmaceuticals’ costs in the health economic bulls-eye

This past weekend, 60 Minutes’ Leslie Stahl asked John Castellani, the president of PhRMA, the pharmaceutical industry’s advocacy (lobby) organization, why the cost of Gleevec, from Novartis, dramatically increased over the 13 years it’s been in the market, while other more expensive competitors have been launched in the period. (Here is the FDA’s announcement of […]

Read full story Comments { 1 }

Health-wear – at Health 2.0, health met fashion, function and care

Wearables met health and medicine at the 8th annual Health 2.0 Conference in Santa Clara, CA, last week. I had the real pleasure of shepherding a wearables panel of five innovators during the conference, in a well-attended session followed by an energetic Q&A. The organizations who demonstrated their tools and brainstormed the wearables market included, […]

Read full story Comments { 2 }

Crossing the digital health chasm between consumers and providers – talking with Dr. Eric Topol

More than twice as many patients than physicians are embracing consumers’ use of new digital technologies to self-diagnose medical conditions on their own. On the other hand, 91% of doctors are concerned about giving patients access to their detailed electronic health records, anticipating patients will feel anxious about the results; only 34% of consumers are […]

Read full story Comments { 0 }

Health on the 2014 Gartner Hype Cycle

Remote health monitoring is in the Trough of Disillusionment. Wearables are at the Peak of Inflated Expectations, with Big Data leapfrogging wearables from the 2013 forecast — both descending toward the Disillusionment Trough. Mobile (remote) health monitoring, however, has fallen into that Trough of Disillusionment as RHM has been undergoing reality checks in the health […]

Read full story Comments { 0 }

NephCure – a rare disease community that’s patient-powered

The burden of chronic kidney disease (CKD) is growing, with one in 10 U.S. adults having some level of CKD.  End-stage renal disease (ESRD) is the last phase of CKD, when dialysis or an organ transplant are required. Nephrotic syndrome is one of the most common forms of CKD, and focal segmental glomerulosclerosis — FSGS […]

Read full story Comments { 0 }